4:06 PM ET
8-K
Leadership Change
IR-Med Leadership Change
IR-Med, Inc. appointed Yaniv Cohen as interim Chief Executive Officer, effective September 14, 2026. Mr. Cohen is a co-founder of the company and previously served as its Chief Scientific Officer and R&D Manager. No new compensatory arrangements were entered into in connection with this appointment.